Overview Dividends

(CCJ) Cameco - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA13321L1085

Uranium, Fuel, Conversion, Reactor, Services

CCJ EPS (Earnings per Share)

EPS Growth (3Y CAGR): -42.59%
EPS Trend (3Y Correlation): 21.6%

CCJ Revenue

Revenue Growth (3Y CAGR): 34.44%
Revenue Trend (3Y Correlation): 77.0%

Description: CCJ Cameco September 29, 2025

Cameco Corp (NYSE:CCJ) is a vertically integrated uranium producer that generates revenue across three business lines: (1) Uranium – exploration, mining, milling, and the sale of uranium concentrate; (2) Fuel Services – conversion, enrichment, and fabrication of nuclear fuel; and (3) Westinghouse – design, construction, and aftermarket support for commercial nuclear reactors.

The company’s customer base spans nuclear utilities in the Americas, Europe, and Asia, positioning it as a primary supplier in a market where long-term contracts dominate pricing and demand is driven by the global push for low-carbon electricity generation.

Key operational metrics from the most recent fiscal year include production of roughly 12.5 million pounds of U₃O₈, cash flow from operations of about $2.1 billion, and a net debt-to-EBITDA ratio of 0.9×, indicating a relatively strong balance sheet for a capital-intensive commodity business.

Sector-wide, the uranium market is currently influenced by three macro drivers: (i) the tightening of supply as legacy mines close, (ii) government policies that earmark nuclear power as a cornerstone of net-zero strategies, and (iii) price volatility stemming from geopolitical tensions that affect both supply chains and the cost of alternative energy sources.

For a deeper dive into Cameco’s valuation metrics and scenario analysis, the ValueRay platform offers a transparent, data-driven framework worth exploring.

CCJ Stock Overview

Market Cap in USD	37,700m
Sub-Industry	Coal & Consumable Fuels
IPO / Inception	1996-03-14

CCJ Stock Ratings

Growth Rating	88.4%
Fundamental	71.3%
Dividend Rating	59.8%
Return 12m vs S&P 500	35.9%
Analyst Rating	4.53 of 5

CCJ Dividends

Dividend Yield 12m	0.13%
Yield on Cost 5y	1.21%
Annual Growth 5y	16.92%
Payout Consistency	94.2%
Payout Ratio	9.3%

CCJ Growth Ratios

Growth Correlation 3m	81.2%
Growth Correlation 12m	65.8%
Growth Correlation 5y	94.7%
CAGR 5y	54.39%
CAGR/Max DD 3y (Calmar Ratio)	1.36
CAGR/Mean DD 3y (Pain Ratio)	5.81
Sharpe Ratio 12m	0.62
Alpha	30.56
Beta	1.181
Volatility	47.09%
Current Volume	4208k
Average Volume 20d	4494.1k
Stop Loss	80.2 (-7.1%)
Signal	0.19

Piotroski VR‑10 (Strict, 0-10) 8.5

Net Income (533.6m TTM) > 0 and > 6% of Revenue (6% = 214.2m TTM)

FCFTA 0.09 (>2.0%) and ΔFCFTA 4.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 33.42% (prev 40.30%; Δ -6.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 1.16b > Net Income 533.6m (YES >=105%, WARN >=100%)

Net Debt (279.7m) to EBITDA (1.14b) ratio: 0.25 <= 3.0 (WARN <= 3.5)

Current Ratio 2.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (435.5m) change vs 12m ago -0.10% (target <= -2.0% for YES)

Gross Margin 29.47% (prev 21.64%; Δ 7.83pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 37.65% (prev 28.26%; Δ 9.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 7.79 (EBITDA TTM 1.14b / Interest Expense TTM 104.2m) >= 6 (WARN >= 3)

Altman Z'' 4.96

(A) 0.12 = (Total Current Assets 1.80b - Total Current Liabilities 608.9m) / Total Assets 9.58b

(B) 0.36 = Retained Earnings (Balance) 3.49b / Total Assets 9.58b

(D) 2.26 = Book Value of Equity 6.43b / Total Liabilities 2.84b

Total Rating: 4.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 71.34

1. Piotroski 8.50pt = 3.50

2. FCF Yield 1.69% = 0.84

3. FCF Margin 25.25% = 6.31

4. Debt/Equity 0.15 = 2.49

5. Debt/Ebitda 0.25 = 2.45

6. ROIC - WACC (= -1.45)% = -1.81

7. RoE 8.27% = 0.69

8. Rev. Trend 77.05% = 5.78

9. EPS Trend 21.64% = 1.08

What is the price of CCJ shares?

As of October 24, 2025, the stock is trading at USD 86.30 with a total of 4,207,999 shares traded.
Over the past week, the price has changed by -5.30%, over one month by -0.68%, over three months by +9.03% and over the past year by +59.89%.

Is Cameco a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Cameco (NYSE:CCJ) is currently (October 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 71.34 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCJ is around 113.64 USD . This means that CCJ is currently undervalued and has a potential upside of +31.68% (Margin of Safety).

Is CCJ a buy, sell or hold?

Cameco has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy CCJ.

Strong Buy: 10
Buy: 9
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CCJ price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	90.8	5.2%
Analysts Target Price	90.8	5.2%
ValueRay Target Price	128.7	49.1%

CCJ Fundamental Data Overview October 18, 2025

Market Cap CAD = 52.72b (37.70b USD * 1.3984 USD.CAD)
P/E Trailing = 99.5287
P/E Forward = 57.8035
P/S = 10.5596
P/B = 7.5722
P/EG = 3.33
Beta = 1.181
Revenue TTM = 3.57b CAD
EBIT TTM = 812.1m CAD
EBITDA TTM = 1.14b CAD
Long Term Debt = 996.0m CAD (from longTermDebt, last quarter)
Short Term Debt = 289.2m CAD (from shortTermDebt, last fiscal year)
Debt = 996.0m CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 279.7m CAD (from netDebt column, last quarter)
Enterprise Value = 53.45b CAD (52.72b + Debt 996.0m - CCE 263.8m)
Interest Coverage Ratio = 7.79 (Ebit TTM 812.1m / Interest Expense TTM 104.2m)
FCF Yield = 1.69% (FCF TTM 901.3m / Enterprise Value 53.45b)
FCF Margin = 25.25% (FCF TTM 901.3m / Revenue TTM 3.57b)
Net Margin = 14.94% (Net Income TTM 533.6m / Revenue TTM 3.57b)
Gross Margin = 29.47% ((Revenue TTM 3.57b - Cost of Revenue TTM 2.52b) / Revenue TTM)
Gross Margin QoQ = 29.31% (prev 34.22%)
Tobins Q-Ratio = 5.58 (Enterprise Value 53.45b / Total Assets 9.58b)
Interest Expense / Debt = 2.25% (Interest Expense 22.4m / Debt 996.0m)
Taxrate = 18.14% (71.1m / 392.0m)
NOPAT = 664.8m (EBIT 812.1m * (1 - 18.14%))
Current Ratio = 2.96 (Total Current Assets 1.80b / Total Current Liabilities 608.9m)
Debt / Equity = 0.15 (Debt 996.0m / totalStockholderEquity, last quarter 6.74b)
Debt / EBITDA = 0.25 (Net Debt 279.7m / EBITDA 1.14b)
Debt / FCF = 0.31 (Net Debt 279.7m / FCF TTM 901.3m)
Total Stockholder Equity = 6.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.57% (Net Income 533.6m / Total Assets 9.58b)
RoE = 8.27% (Net Income TTM 533.6m / Total Stockholder Equity 6.45b)
RoCE = 10.90% (EBIT 812.1m / Capital Employed (Equity 6.45b + L.T.Debt 996.0m))
RoIC = 8.76% (NOPAT 664.8m / Invested Capital 7.59b)
WACC = 10.21% (E(52.72b)/V(53.72b) * Re(10.37%) + D(996.0m)/V(53.72b) * Rd(2.25%) * (1-Tc(0.18)))
Discount Rate = 10.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.15%
[DCF Debug] Terminal Value 74.25% ; FCFE base≈727.9m ; Y1≈898.0m ; Y5≈1.53b
Fair Price DCF = 40.44 (DCF Value 17.61b / Shares Outstanding 435.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 21.64 | EPS CAGR: -42.59% | SUE: -1.30 | # QB: 0
Revenue Correlation: 77.05 | Revenue CAGR: 34.44% | SUE: 0.32 | # QB: 0

Additional Sources for CCJ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle